TY - JOUR
T1 - HIV-Related Skin Disease in the Era of Antiretroviral Therapy
T2 - Recognition and Management
AU - Chelidze, Khatiya
AU - Thomas, Cristina
AU - Chang, Aileen Yenting
AU - Freeman, Esther Ellen
N1 - Funding Information:
Funding Dr. Freeman’s effort on this manuscript was supported by the Dermatology Foundation and NIH K23 AI136579.
Funding Information:
The authors would like to acknowledge Ms. Julia Foote (Massachusetts General Hospital) for her assistance in editing the manuscript.
Publisher Copyright:
© 2019, Springer Nature Switzerland AG.
PY - 2019/6/1
Y1 - 2019/6/1
N2 - Antiretroviral therapy (ART) has revolutionized the treatment and prognosis of people living with HIV (PLHIV). With increased survival and improved overall health, PLHIV are experiencing dermatologic issues both specific to HIV and common to the general population. In this new era of ART, it is crucial for dermatologists to have a strong understanding of the broad range of cutaneous disease and treatment options in this unique population. In this review, we outline the most common skin diseases in PLHIV, including HIV-associated malignancies, inflammatory conditions, and infections, and focus on the role of ART in altering epidemiology, clinical features, diagnosis, and treatment of cutaneous conditions.
AB - Antiretroviral therapy (ART) has revolutionized the treatment and prognosis of people living with HIV (PLHIV). With increased survival and improved overall health, PLHIV are experiencing dermatologic issues both specific to HIV and common to the general population. In this new era of ART, it is crucial for dermatologists to have a strong understanding of the broad range of cutaneous disease and treatment options in this unique population. In this review, we outline the most common skin diseases in PLHIV, including HIV-associated malignancies, inflammatory conditions, and infections, and focus on the role of ART in altering epidemiology, clinical features, diagnosis, and treatment of cutaneous conditions.
UR - http://www.scopus.com/inward/record.url?scp=85066126571&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85066126571&partnerID=8YFLogxK
U2 - 10.1007/s40257-019-00422-0
DO - 10.1007/s40257-019-00422-0
M3 - Review article
C2 - 30806959
AN - SCOPUS:85066126571
SN - 1175-0561
VL - 20
SP - 423
EP - 442
JO - American Journal of Clinical Dermatology
JF - American Journal of Clinical Dermatology
IS - 3
ER -